1. Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis

   • Veronica Ravano
   • Gian Franco Piredda
   • Manuela Vaneckova

   Original Communication Open access 11 October 2023 Pages: 631 - 641

   

2. Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension

   • Ludwig Kappos
   • Anthony Traboulsee
   • Stephen L. Hauser

   Original Communication Open access 31 October 2023 Pages: 642 - 657

   

3. Peering further into the mind’s eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis

   • Thomas J. Covey
   • Daniel Golan
   • Mark Gudesblatt

   Original Communication 13 December 2023 Pages: 658 - 673

   

4. Multiple sclerosis in the elderly: a retrospective cohort study

   • Anne Zinganell
   • Georg Göbel
   • Florian Deisenhammer

   Original Communication 19 October 2023 Pages: 674 - 687

   

5. Emotional burden among MS patients: associations between specific chronic pain diagnoses and psychological features

   • Michal Rivel
   • Anat Achiron
   • Ruth Defrin

   Original Communication 24 October 2023 Pages: 688 - 698

   

6. COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients

   • Alvino Bisecco
   • Federica Matrone
   • the OCREVID study group on behalf of the Italian MS Register

   Original Communication Open access 20 November 2023 Pages: 699 - 710

   

7. Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium

   • Dejan Jakimovski
   • Katelyn S. Kavak
   • the New York State Multiple Sclerosis Consortium (NYSMSC)

   Original Communication 23 November 2023 Pages: 711 - 722

   

8. Rasmussen’s syndrome treated with anakinra

   • Abdullah Arcan
   • Esra Koçhan Kızılkılıç
   • Çiğdem Özkara

   Short Commentary 03 November 2023 Pages: 723 - 726

   

9. Serum sickness in a multiple sclerosis patient treated with ocrelizumab

   • Vittorio Mantero
   • Christian Cordano
   • Andrea Salmaggi

   Letter to the Editors 31 October 2023 Pages: 727 - 728

10. Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod

    • Lina Jeantin
    • Natalia Shor
    • Valérie Pourcher

    Letter to the Editors 01 November 2023 Pages: 729 - 732

    

11. Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts

    • Laynie Dratch
    • Meron Azage
    • Colin A. Ellis

    Review 27 October 2023 Pages: 733 - 747

    

12. AMPK role in epilepsy: a promising therapeutic target?

    • Yingbei Qi
    • Yong-mei Zhang
    • Jia Li

    Review 27 November 2023 Pages: 748 - 771

    

13. Relationships between intracranial arterial dolichoectasia and small vessel disease in patients with ischaemic stroke: a systematic review and meta-analysis

    • Kitti Thiankhaw
    • Hatice Ozkan
    • David J. Werring

    Review Open access 29 November 2023 Pages: 772 - 781

    

14. The comorbidity and co-medication profile of patients with progressive supranuclear palsy

    • Stephan Greten
    • Florian Wegner
    • Martin Klietz

    Original Communication Open access 06 October 2023 Pages: 782 - 793

    

15. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis

    • Francesco Gentile
    • Alessio Maranzano
    • Nicola Ticozzi

    Original Communication Open access 06 October 2023 Pages: 794 - 803

    

16. Implementation of a 7T Epilepsy Task Force consensus imaging protocol for routine presurgical epilepsy work-up: effect on diagnostic yield and lesion delineation

    • Gilbert Hangel
    • Gregor Kasprian
    • Karl Roessler

    Original Communication Open access 07 October 2023 Pages: 804 - 818

    

17. Effects of pupil size in video head-impulse tests

    • Ho-Jin Yoon
    • Jeong-Heon Lee
    • Ji-Soo Kim

    Original Communication 08 October 2023 Pages: 819 - 825

    

18. Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients

    • Rosa De Micco
    • Federica Di Nardo
    • Alessandro Tessitore

    Original Communication Open access 09 October 2023 Pages: 826 - 834

    

19. Current management of primary mitochondrial disorders in EU countries: the European Reference Networks survey

    • Michelangelo Mancuso
    • Piervito Lopriore
    • Teresinha Evangelista

    Original Communication Open access 13 October 2023 Pages: 835 - 840

    

20. Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)

    • Fine Dietrich
    • Alexandros A. Polymeris
    • Isabelle Arnet

    Original Communication Open access 13 October 2023 Pages: 841 - 851

    

21. Longitudinal predictors of health-related quality of life in isolated dystonia

    • Johanna Junker
    • James Hall
    • Norbert Brüggemann

    Original Communication Open access 15 October 2023 Pages: 852 - 863

    

22. Mitochondrial myopathy without extraocular muscle involvement: a unique clinicopathologic profile

    • Yan Lin
    • Jiayin Wang
    • Kunqian Ji

    Original Communication 17 October 2023 Pages: 864 - 876

    

23. Clinical outcome after thrombectomy in patients with MeVO stroke: importance of clinical and technical factors

    • Terje Nome
    • Brian Enriquez
    • Mona Beyer

    Original Communication Open access 17 October 2023 Pages: 877 - 886

    

24. Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders

    • I. P. Hannigan
    • S. M. Rosengren
    • S. R. D. Watson

    Original Communication Open access 17 October 2023 Pages: 887 - 898

    

25. Machine learning using multimodal and autonomic nervous system parameters predicts clinically apparent stroke-associated pneumonia in a development and testing study

    • Alexander Nelde
    • Laura Krumm
    • Christian Meisel

    Original Communication Open access 18 October 2023 Pages: 899 - 908

    

26. Associations of C-reactive protein with depressive symptoms over time after mild to moderate ischemic stroke in the PROSCIS-B cohort

    • Viktoria L. K. Schaeff
    • Pia S. Sperber
    • Thomas G. Liman

    Original Communication Open access 18 October 2023 Pages: 909 - 917

    

27. Cognitive impairment associated with cerebellar volume loss in spinocerebellar ataxia type 3

    • Zhi-Xian Ye
    • Jin Bi
    • OSCCAR Investigators

    Original Communication 18 October 2023 Pages: 918 - 928

    

28. Disease survival and progression in TARDBP ALS patients from Sardinia, Italy

    • Giuseppe Borghero
    • Francesca Pili
    • Giovanni Defazio

    Original Communication 19 October 2023 Pages: 929 - 934

    

29. Recurrence and long-term outcomes of Tolosa-Hunt syndrome

    • Hyun-Jae Kim
    • Sun-Uk Lee
    • Ji-Soo Kim

    Original Communication 19 October 2023 Pages: 935 - 943

    

30. Cardiac sympathetic “morbidity” might reflect the neurobiology of early Parkinson’s disease

    • Sang-Won Yoo
    • Yoon-Sang Oh
    • Joong-Seok Kim

    Original Communication 21 October 2023 Pages: 944 - 954

    

31. High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis

    • Barbara Iazzolino
    • Maurizio Grassano
    • Adriano Chiò

    Original Communication Open access 25 October 2023 Pages: 955 - 961

    

32. Gray matter loss relates to dual task gait in Lewy body disorders and aging

    • Arsenije Subotic
    • Myrlene Gee
    • Canadian Consortium on Neurodegeneration in Aging (CCNA)

    Original Communication 30 October 2023 Pages: 962 - 975

    

33. Transcriptomic analysis reveals associations of blood-based A-to-I editing with Parkinson’s disease

    • Weimin Li
    • Hao Wu
    • Ganqiang Liu

    Original Communication 30 October 2023 Pages: 976 - 985

    

34. Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3

    • Carlos Pablo de Fuenmayor-Fernández de la Hoz
    • Vincenzo Lupo
    • Cristina Domínguez-González

    Original Communication 31 October 2023 Pages: 986 - 994

    

35. Yield of non-invasive imaging in MRI-negative focal epilepsy

    • Christian Czarnetzki
    • Laurent Spinelli
    • Margitta Seeck

    Original Communication Open access 01 November 2023 Pages: 995 - 1003

    

36. Differentiation of speech in Parkinson’s disease and spinocerebellar degeneration using deep neural networks

    • Katsuki Eguchi
    • Hiroaki Yaguchi
    • Ichiro Yabe

    Short Commentary 21 November 2023 Pages: 1004 - 1012

    

37. Case report of palatal tremor as a feature of CASPR2 autoimmune encephalitis

    • Giovanna S. Manzano
    • Caleb McEntire
    • Nagagopal Venna

    Letter to the Editors 11 October 2023 Pages: 1013 - 1014

    

38. Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report

    • Adolfo Jiménez-Huete
    • Ana Patiño-García
    • Nicolás Pérez

    Letter to the Editors 13 October 2023 Pages: 1015 - 1018

    

39. Rapidly progressive moyamoya vasculopathy stabilized with immunotherapy in aicardi-goutières syndrome

    • Jenae Vancura
    • Natalie K. Boyd
    • Jonathan D. Santoro

    Letter to the Editors 19 October 2023 Pages: 1019 - 1022

    

40. Bilateral vestibulopathy in RFC1-positive CANVAS is distinctly different compared to FGF14-linked spinocerebellar ataxia 27B

    • Max Borsche
    • Mirja Thomsen
    • Norbert Brüggemann

    Letter to the Editors Open access 20 October 2023 Pages: 1023 - 1027

    

41. Primary progressive aphasia: six questions in search of an answer

    • Christopher R. S. Belder
    • Charles R. Marshall
    • Jason D. Warren

    Neurological Update Open access 31 October 2023 Pages: 1028 - 1046

    

42. Neurosarcoidosis

    • Desmond P. Kidd

    Neurological Update 02 November 2023 Pages: 1047 - 1055

    

43. Novel biomarkers and neuroimaging techniques in Parkinson’s disease

    • A. Saw
    • S. Bari
    • Neil P. Robertson

    Journal club Open access 17 January 2024 Pages: 1056 - 1058

44. The DeMyers: Marian (1922–2012) and William (1924–2008)

    • Lazaros C. Triarhou

    Pioneers in Neurology 07 December 2023 Pages: 1059 - 1061

    

45. Correction to: Neurological update: non-motor symptoms in atypical parkinsonian syndromes

    • Piriyankan Ananthavarathan
    • B. Patel
    • N. Malek

    Correction Open access 27 December 2023 Pages: 1062 - 1062